← Leaderboards

Jerome Ritz

Cornell University

Google Scholar ↗PubMed ↗ORCID ↗

$48,203,511

Attributed

$53,031,586

Total exposure

31

Grants

24

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $6M · FY2005–25

$10M$7.5M$5M$2.5M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$57,495,618 · 32

By mechanism

P30$25,608,186 · 7

P01$17,140,391 · 17

R01$10,293,576 · 4

U19$2,229,982 · 2

UG1$1,793,979 · 1

P50$429,504 · 1

Top collaborators

Robert Jon Soiffer10 shared
Iwijn De Vlaminck5 shared

Others in their field

Top investigators on “Cells”

Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
Barton F Haynes · Duke University$457,457,619
David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
Dennis R. Burton · Scripps Research Institute$278,781,854
Mary M Horowitz · Medical College Of Wisconsin$237,383,608

Research focus

CellsLaboratoriesClinical TrialsProgramsResearch PersonnelHematopoietic Stem Cell TransplantationSamplingTransplantationEnrollmentPlasmaMonitorAllogenicImmuneFlow CytometryLeukemiaT-LymphocyteReconstitutionMononuclearCryopreservationPlayProceduresDana-Farber Cancer InstituteMissionAntigen Targeting

Grant awards (116)

Shared Resource Management$5,534,524

P30 · FY2025 · CA · contact PI

Biobanking and Immunologic Monitoring$275,076

P01 · FY2025 · HL · contact PI

Sample Processing and Banking$141,970

P01 · FY2025 · CA · contact PI

Shared Resource Management$4,576,095

P30 · FY2024 · CA · contact PI

Epigenetic Profiling of circulating cell-free DNA for the Monitoring of Graft-Versus-Host Disease after Hematopoietic Cell Transplantation$650,319

R01 · FY2024 · AI

Biobanking and Immunologic Monitoring$268,481

P01 · FY2024 · HL · contact PI

Shared Resource Management$4,724,383

P30 · FY2023 · CA · contact PI

Epigenetic Profiling of circulating cell-free DNA for the Monitoring of Graft-Versus-Host Disease after Hematopoietic Cell Transplantation$653,663

R01 · FY2023 · AI

Sample Processing and Immune Assessment$316,580

P01 · FY2023 · CA · contact PI

Biobanking and Immunologic Monitoring$275,138

P01 · FY2023 · HL · contact PI

Cell Manipulation Core Facility$2

P30 · FY2023 · CA · contact PI

Shared Resource Management$4,723,149

P30 · FY2022 · CA · contact PI

Epigenetic Profiling of circulating cell-free DNA for the Monitoring of Graft-Versus-Host Disease after Hematopoietic Cell Transplantation$656,855

R01 · FY2022 · AI

Sample Processing and Immune Assessment$317,918

P01 · FY2022 · CA · contact PI

Biobanking and Immunologic Monitoring$282,597

P01 · FY2022 · HL · contact PI

Cell Manipulation Core Facility$2

P30 · FY2022 · CA · contact PI

Epigenetic Profiling of circulating cell-free DNA for the Monitoring of Graft-Versus-Host Disease after Hematopoietic Cell Transplantation$733,701

R01 · FY2021 · AI

Core 02: Cell Manipulation Core Facility$491,729

P30 · FY2021 · CA · contact PI

Sample Processing and Immune Assessment$324,407

P01 · FY2021 · CA · contact PI

BIOSPECIMENS AND XENOGRAFT$20,551

P50 · FY2021 · CA · contact PI

Epigenetic Profiling of circulating cell-free DNA for the Monitoring of Graft-Versus-Host Disease after Hematopoietic Cell Transplantation$752,613

R01 · FY2020 · AI

Core 02: Cell Manipulation Core Facility$491,616

P30 · FY2020 · CA · contact PI

Sample Processing and Immune Assessment$324,407

P01 · FY2020 · CA · contact PI

Safety and Feasibility of Cultivated Autologous Limbal Epithelial Cell (CALEC) Transplantation in the Treatment of Limbal Stem Cell Deficiency$199,820

UG1 · FY2020 · EY · contact PI

Core 02: Cell Manipulation Core Facility$2,949

P30 · FY2020 · CA · contact PI

Safety and Feasibility of Cultivated Autologous Limbal Epithelial Cell (CALEC) Transplantation in the Treatment of Limbal Stem Cell Deficiency$1

UG1 · FY2020 · EY · contact PI

Core 02: Cell Manipulation Core Facility$489,985

P30 · FY2019 · CA · contact PI

Safety and Feasibility of Cultivated Autologous Limbal Epithelial Cell (CALEC) Transplantation in the Treatment of Limbal Stem Cell Deficiency$395,380

UG1 · FY2019 · EY · contact PI

Sample Processing and Immune Assessment$324,407

P01 · FY2019 · CA · contact PI

Core B: Cell Banking and Immune Assessment Core$249,396

P01 · FY2019 · CA · contact PI

Project 3: Humoral Targets and B Cell Biology in Chronic Graft-vs.-Host Disease$153,601

P01 · FY2019 · CA · contact PI

Core 02: Cell Manipulation Core Facility$6,169

P30 · FY2019 · CA · contact PI

Safety and Feasibility of Cultivated Autologous Limbal Epithelial Cell (CALEC) Transplantation in the Treatment of Limbal Stem Cell Deficiency$577,567

UG1 · FY2018 · EY · contact PI

Core 02: Cell Manipulation Core Facility$491,646

P30 · FY2018 · CA · contact PI

Core B: Cell Banking and Immune Assessment Core$255,510

P01 · FY2018 · CA · contact PI

BIOSPECIMENS AND XENOGRAFT$183,623

P50 · FY2018 · CA · contact PI

Project 3: Humoral Targets and B Cell Biology in Chronic Graft-vs.-Host Disease$159,715

P01 · FY2018 · CA · contact PI

BIOSPECIMENS AND XENOGRAFT$43,634

P50 · FY2018 · CA · contact PI

Core 02: Cell Manipulation Core Facility$11,431

P30 · FY2018 · CA · contact PI

Core 02: Cell Manipulation Core Facility$5,849

P30 · FY2018 · CA · contact PI

Core 02: Cell Manipulation Core Facility$5,124

P30 · FY2018 · CA · contact PI

Core 02: Cell Manipulation Core Facility$3,835

P30 · FY2018 · CA · contact PI

Core 02: Cell Manipulation Core Facility$1,603

P30 · FY2018 · CA · contact PI

Manipulation of Immune Responsiveness after Hematopoietic Cell Transplantation$700,000

R01 · FY2017 · CA

Safety and Feasibility of Cultivated Autologous Limbal Epithelial Cell (CALEC) Transplantation in the Treatment of Limbal Stem Cell Deficiency$621,211

UG1 · FY2017 · EY · contact PI

Core 02: Cell Manipulation Core Facility$507,245

P30 · FY2017 · CA · contact PI

Reconstitution of Regulatory T Cells After Stem Cell Transplantation$500,000

R01 · FY2017 · CA · contact PI

Core B: Cell Banking and Immune Assessment Core$255,510

P01 · FY2017 · CA · contact PI

BIOSPECIMENS AND XENOGRAFT$181,696

P50 · FY2017 · CA · contact PI

Project 3: Humoral Targets and B Cell Biology in Chronic Graft-vs.-Host Disease$159,715

P01 · FY2017 · CA · contact PI

Manipulation of Immune Responsiveness after Hematopoietic Cell Transplantation$700,000

R01 · FY2016 · CA

Reconstitution of Regulatory T Cells After Stem Cell Transplantation$500,000

R01 · FY2016 · CA · contact PI

Cell Manipulation$323,768

P30 · FY2016 · CA · contact PI

Core B: Cell Banking and Immune Assessment Core$255,510

P01 · FY2016 · CA · contact PI

Project 3: Humoral Targets and B Cell Biology in Chronic Graft-vs.-Host Disease$159,715

P01 · FY2016 · CA · contact PI

Manipulation of Immune Responsiveness after Hematopoietic Cell Transplantation$700,000

R01 · FY2015 · CA

Reconstitution of Regulatory T Cells After Stem Cell Transplantation$500,000

R01 · FY2015 · CA · contact PI

Cell Manipulation$324,122

P30 · FY2015 · CA · contact PI

Core B: Cell Banking and Immune Assessment Core$262,387

P01 · FY2015 · CA · contact PI

Project 3: Humoral Targets and B Cell Biology in Chronic Graft-vs.-Host Disease$166,592

P01 · FY2015 · CA · contact PI

Manipulation of Immune Responsiveness after Hematopoietic Cell Transplantation$924,000

R01 · FY2014 · CA

Reconstitution of Regulatory T Cells After Stem Cell Transplantation$485,000

R01 · FY2014 · CA · contact PI

Cell Manipulation$309,200

P30 · FY2014 · CA · contact PI

Cell Processing and Immune Assessment$262,216

P01 · FY2014 · CA · contact PI

Manipulation of Immune Responsiveness after Hematopoietic Cell Transplantation$700,000

R01 · FY2013 · CA

Reconstitution of Regulatory T Cells After Stem Cell Transplantation$500,000

R01 · FY2013 · CA · contact PI

Cell Manipulation$298,895

P30 · FY2013 · CA · contact PI

Cell Banking and Immune Assessment$285,702

P01 · FY2013 · CA · contact PI

Human Minor Histocompatibity Antigens$283,037

P01 · FY2013 · CA · contact PI

Cell Processing and Immune Assessment$282,875

P01 · FY2013 · CA · contact PI

Cell Banking and Immune Assessment$345,978

P01 · FY2012 · CA · contact PI

Human Minor Histocompatibity Antigens$339,936

P01 · FY2012 · CA · contact PI

Cell Manipulation$324,107

P30 · FY2012 · CA · contact PI

Cell Processing and Immune Assessment$275,994

P01 · FY2012 · CA · contact PI

PATIENT SAMPLE REPOSITORY AND SPECIALIZED FLOW CYTOMETRY$178,441

P01 · FY2012 · CA · contact PI

Cell Banking and Immune Assessment$347,564

P01 · FY2011 · CA · contact PI

Human Minor Histocompatibity Antigens$341,399

P01 · FY2011 · CA · contact PI

Cell Processing and Immune Assessment$278,501

P01 · FY2011 · CA · contact PI

PATIENT SAMPLE REPOSITORY AND SPECIALIZED FLOW CYTOMETRY$178,125

P01 · FY2011 · CA · contact PI

Core - Cell Manipulation$430,556

P30 · FY2010 · CA · contact PI

Cell Banking and Immune Assessment$356,674

P01 · FY2010 · CA · contact PI

Human Minor Histocompatibity Antigens$350,349

P01 · FY2010 · CA · contact PI

Cell Processing and Immune Assessment$159,123

P01 · FY2010 · CA · contact PI

PATIENT SAMPLE REPOSITORY AND SPECIALIZED FLOW CYTOMETRY$158,256

P01 · FY2010 · CA · contact PI

Core - Cell Manipulation$443,555

P30 · FY2009 · CA · contact PI

Reconstitution of Regulatory T Cells after Allogeneic Stem Cell Transplantation$379,643

U19 · FY2009 · AI · contact PI

Cell Banking and Immune Assessment$363,561

P01 · FY2009 · CA · contact PI

Human Minor Histocompatibity Antigens$357,115

P01 · FY2009 · CA · contact PI

PATIENT SAMPLE REPOSITORY AND SPECIALIZED FLOW CYTOMETRY$155,598

P01 · FY2009 · CA · contact PI

Assessment of Immunity to Vaccinia and MVA$626,183

U19 · FY2008 · AI · contact PI

Core - Cell Manipulation$407,319

P30 · FY2008 · CA · contact PI

Reconstitution of Regulatory T Cells after Allogeneic Stem Cell Transplantation$370,035

U19 · FY2008 · AI · contact PI

PATIENT SAMPLE REPOSITORY AND SPECIALIZED FLOW CYTOMETRY$151,141

P01 · FY2008 · CA · contact PI

Core - Cell Manipulation$437,771

P30 · FY2007 · CA · contact PI

Human Minor Histocompatibility Antigens$411,946

P01 · FY2007 · HL · contact PI

Reconstitution of Regulatory T Cells after Allogeneic Stem Cell Transplantation$368,066

U19 · FY2007 · AI · contact PI

Core--Chimerism and Immunologic Recovery$356,650

P01 · FY2007 · HL · contact PI

Reconstitution of Regulatory T Cells after Allogeneic Stem Cell Transplantation$351,982

U19 · FY2006 · AI · contact PI

Core - Cell Manipulation$241,557

P30 · FY2006 · CA · contact PI

Human Minor Histocompatibility Antigens$185,997

P01 · FY2006 · HL · contact PI

Core--Chimerism and Immunologic Recovery$146,883

P01 · FY2006 · HL · contact PI

Reconstitution of Regulatory T Cells after Allogeneic Stem Cell Transplantation$134,073

U19 · FY2005 · AI

PROGRAM PROJECT IN ALLOGENEIC STEM CELL TRANSPLANTATION$1,212,062

P01 · FY2003 · AI

PROGRAM PROJECT IN ALLOGENEIC STEM CELL TRANSPLANTATION$1,104,969

P01 · FY2002 · AI

TARGETS OF ALLOIMMUNITY AFTER STEM CELL TRANSPLANTATION$247,466

P01 · FY2002 · AI

PROGRAM PROJECT IN ALLOGENEIC STEM CELL TRANSPLANTATION$1,157,138

P01 · FY2001 · AI

REGULATION OF HUMAN NK CELL FUNCTION$322,729

R01 · FY2001 · CA

TARGETS OF ALLOIMMUNITY AFTER STEM CELL TRANSPLANTATION$247,466

P01 · FY2001 · AI

IMMUNOLOGIC STRATEGIES FOR THE TREATMENT OF ACUTE LEUKEMIA$0

P01 · FY2001 · CA

CORE--CLINICAL RESEARCH SUPPORT COMPONENT$0

P01 · FY2001 · CA

PROGRAM PROJECT IN ALLOGENEIC STEM CELL TRANSPLANTATION$989,863

P01 · FY2000 · AI

REGULATION OF HUMAN NK CELL FUNCTION$314,696

R01 · FY2000 · CA

TARGETS OF ALLOIMMUNITY AFTER STEM CELL TRANSPLANTATION$247,466

P01 · FY2000 · AI

CORE--CLINICAL RESEARCH SUPPORT COMPONENT$226,134

P01 · FY2000 · CA

IMMUNOLOGIC STRATEGIES FOR THE TREATMENT OF ACUTE LEUKEMIA$226,134

P01 · FY2000 · CA

CORE--CELL MANIPULATION$0

P30 · FY2000 · CA